Home›Companies›Biotech & Pharma›Mimivax

Mimivax Inc.

Updated Oct 29, 2026·Latest SEC filing Jul 12, 2024·Suggest an edit

About Mimivax

Mimivax is a private company based in Buffalo, New York. It has reported $5,781,000 raised in one offering on Form D since July 2024. Its chief executive is Michael Ciesielski.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 6, 2023Jul 12, 2024$5,781,000fully sold16$361KDebtRule 506(c)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Mimivax's Form D filed Jul 12, 2024.

MC
Michael Ciesielski
Chief Executive Officer and director
MS
SF

Sources

  1. SECMIMIVAX INC. filing history